Nasdaq biol.

LAKE FOREST, Calif., Sept. 13, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering of 75,000 units (the "Units"), with each Unit consisting of one share of BIOLASE's Series J Convertible Redeemable …100.03%. Get the latest BIOLASE Inc (BIOL) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that based on currently available information, preliminary 2022 fourth quarter revenue is expected to be between ...Like biting into a piece of aluminum foil, dental laser manufacturer BioLase (NASDAQ:BLTI) jarred the market's dentures with an announcement that first-quarter revenues would be well below ...LAKE FOREST, Calif., Sept. 13, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten ...

BIOLASE, Inc. (NASDAQ: BIOL), the world's leading dental laser company, today released the following statement in response to the attempt by Sonendo, Inc., through its wholly-owned subsidiary ...Earnings announcement* for BIOL: Nov 09, 2022. Biolase, Inc. is estimated to report earnings on 11/09/2022. The upcoming earnings date is derived from an algorithm based on a company's historical ...

FOOTHILL RANCH, Calif., May 3, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today sent the following letter to stockholders regarding the upcoming 2021 ...

LAKE FOREST, Calif., June 28, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that it has entered into a securities purchase agreement with a ...8 Nov 2023 ... (NASDAQ: BIOL), the global leader in dental lasers, today announced groundbreaking findings from a 12-month follow-up to a clinical trial ...BIOLASE, Inc. (NASDAQ:BIOL) Q1 2022 Earnings Conference Call May 12, 2022 4:30 PM ETCompany Participants. Todd Kehrli - Investor Relations, EVC Group. John Beaver - President and Chief Executive ...Institutional Holdings information can be used to gauge the volatility and value on the company’s stock. $173.46 -0.20. VinFast Auto Ltd. Ordinary Shares. $8.11 +0.06 +0.75%. Find the latest ...

Graphite Bio, Inc. (Nasdaq – GRPH) Under the terms of the agreement, Graphite Bio will merge with LENZ Therapeutics in an all-stock transaction. Under the …

BIOL After-Hours Quotes. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary ...

BIOL Real-Time Quotes Real-time Data is provided using Nasdaq Last Sale Data data.nasdaq.com About Real-Time Quotes Nasdaq provides NLS Volume, Previous Close, Today's High & Low, and the... Jun 13, 2021 · Biolase Inc (NASDAQ:BIOL) is not the least popular stock in this group but hedge fund interest is still below average. Our overall hedge fund sentiment score for BIOL is 19.8. Stocks with higher ... Real time Biolase (BIOL) stock price quote, stock graph, news & analysis. BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release second quarter 2023 financial and operating results on Thursday, August 10, 2023, after the ...Fiscal Q3 2023 ended 9/30/23. Reported on 11/9/23. Get the latest BIOLASE Inc (BIOL) real-time quote, historical performance, charts, and other financial information to help …Aug 10, 2023 · BIOLASE, Inc. (NASDAQ:NASDAQ:BIOL) Q2 2023 Earnings Conference Call August 10, 2023 4:30 PM ETCompany ParticipantsTodd Kehrli - EVC GroupJohn Beaver -... BIOL U.S.: Nasdaq Biolase Inc. Watch list NEW Set a price target alert After Hours Last Updated: Dec 1, 2023 7:47 p.m. EST Delayed quote $ 1.1600 0.01 0.87% After Hours Volume: 175 Advanced...

BIOL Biolase Inc Form 8-K - Current report BIOLASE, INC false 0000811240 0000811240 2023-11-14 2023-11-14 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K ...The 36-month beta value for BIOL is also noteworthy at 1.33. There are mixed opinions on the stock, with 3 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”. The average price estimated by analysts for BIOL is $16.33, which is $14.66 above than the current price.BIOLASE, Inc. (NASDAQ:BIOL) rose 9% to $0.5707 in pre-market trading after gaining 9% on Friday. The company, last month, was granted US patent for 'Dental laser interface system and method.'BIOL Biolase Inc Form 8-K - Current report BIOLASE, INC false 0000811240 0000811240 2023-11-14 2023-11-14 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K ...BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the closing of its previously announced underwritten public offering of 175,000 units ...The Nasdaq Capital Market requires, among other things, that a listing a company's common stock maintain a minimum bid price of at least $1.00 per share. Information for BIOLASE Stockholders

Nasdaq +78.81(+0.55%) Russell 2000 +53.62(+2.96%) Crude Oil 74.38 -1.58(-2.08%) Gold 2,091.70 +34.50(+1.68%) BIOLASE, Inc. (BIOL) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W...BIOL- running earnings 8/10 LONG BIOL had a triple top in late July so this is a logical long target at 8,0, With earnings in less than two days, volumes above the mean in the past couple of days and a decent price-volume product trend coupled with a Price Monetum Oscillator without any signs of topping out in a momentum stall BIOL had a triple top in late July so this is a logical long target ...

Of the funds tracked by Insider Monkey, Hal Mintz’s Sabby Capital has the biggest position in Biolase Inc (NASDAQ:BIOL), worth close to $0.1 million, comprising less than 0.1%% of its total 13F ...Nov 8, 2023 · BIOL) stock’s latest price update. The stock price of Biolase Inc (NASDAQ: BIOL) has jumped by 6.01 compared to previous close of 1.58. Despite this, the company has seen a fall of -0.30% in its stock price over the last five trading days. FOOTHILL RANCH, Calif., May 16, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, today announced that it has received notice from the Nasdaq Stock Market LLC ...01 Mar, 2022, 16:15 ET. FOOTHILL RANCH, Calif., March 1, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, today announced that its Board of Directors ...U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 100 points on Thursday. The Dow traded up 0.61% to 34,784.94 while the NASDAQ rose 0.71% to 13,911.78 ...Jan 10, 2023 · LAKE FOREST, Calif., Jan. 10, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten ... Nov 22, 2023 · BIOL Biolase Inc Statement of Ownership (sc 13g) By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction ... Nov 27, 2023 · The latest price target for . Biolase (NASDAQ: BIOL) was reported by Lake Street on Wednesday, May 31, 2023.The analyst firm set a price target for 0.40 expecting BIOL to fall to within 12 months ... 2 analysts have issued 1-year price objectives for BIOLASE's shares. Their BIOL share price targets range from $4.00 to $150.00. On average, they anticipate the company's stock price to reach $77.00 in the next year. This suggests a possible upside of 6,900.0% from the stock's current price.Biolase (NASDAQ: BIOL) stock is surging more than 26% with heavy trading this morning. Biodexa Pharmaceuticals (NASDAQ: BDRX) shares are gaining over 19% as a prospectus goes into effect.

The company's shares jumped 32.6% to $3.46 in premarket trading. Tracon pharmaceuticals, inc.'s shares surged 116.9% after reporting better- than-expected sales. BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. Its proprietary systems allow dentists, periodontists ...

Biolase, Inc. is estimated to report earnings on 11/09/2022. The upcoming earnings date is derived from an algorithm based on a company's historical reporting …

May-24-23 09:14AM. BIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series H Convertible Redeemable Preferred Stock and Warrants. (PR Newswire) -39.91%. May-11-23 04:36PM. Biolase: Q1 Earnings Snapshot.Of the funds tracked by Insider Monkey, Hal Mintz’s Sabby Capital has the biggest position in Biolase Inc (NASDAQ:BIOL), worth close to $0.1 million, comprising less than 0.1%% of its total 13F ...About · Highlight. A world's leading dental laser company. Industry · Exchange. NASDAQ · Listing Date. 11/12/1992 · Established Date · Full-time Employees.Nasdaq +78.81(+0.55%) Russell 2000 +53.62(+2.96%) Crude Oil 74.38 -1.58(-2.08%) Gold 2,091.70 +34.50(+1.68%) BIOLASE, Inc. (BIOL) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W... IRVINE, Calif., Feb. 5, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has entered into an underwriting agreement with Maxim Group ...BIOL / Biolase Inc (NASDAQ) - Forecast, Price Target, Estimates, Predictions.Dec 5, 2023 · BIOL) stock’s latest price update. Biolase Inc (NASDAQ: BIOL) has experienced a rise in its stock price by 31.30 compared to its previous closing price of 1.15. However, the company has seen a gain of 30.17% in its stock price over the last five trading days. Benzinga reported 2023-08-04 that The most oversold stocks in the health care sector ... IRVINE, Calif., Dec. 1, 2014 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in lasers, today introduced the EPIC™ X diode laser, the company's premier and most complete diode ...BIOL Biolase Inc Statement of Ownership (sc 13g) By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction ...LAKE FOREST, Calif., Jan. 10, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten ...What is BIOLASE's consensus rating and price target? According to the issued ratings of 2 analysts in the last year, the consensus rating for BIOLASE stock is Buy based on the current 2 buy ratings for BIOL. The average twelve-month price prediction for BIOLASE is $77.00 with a high price target of $150.00 and a low price target of $4.00.

Find the latest SEC Filings data for Biolase, Inc. Common Stock (BIOL) at Nasdaq.com. LAKE FOREST, Calif., Feb. 9, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that the Company has been awarded a Top Workplaces 2022 honor by the Inland News Group. This award is in addition to the Top Workplaces 2022 honor from the Orange County Register, which …Jul 26, 2023 · 26 Jul, 2023, 16:30 ET. COMMON STOCK WILL BEGIN TRADING ON SPLIT-ADJUSTED BASIS ON JULY 28, 2023. LAKE FOREST, Calif., July 26, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ) ("BIOLASE" or the ... Instagram:https://instagram. how much is a chiropractic session without insuranceelli lilly stockvfiax pricewill thinkorswim go away 28 Feb, 2019, 08:00 ET. IRVINE, Calif., Feb. 28, 2019 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, announced the appointment of Sinclair Dental Co. Ltd, the ...BIOL Sales Forecast. Next quarter’s sales forecast for BIOL is $14.75M with a range of $13.35M to $16.70M. The previous quarter’s sales results were $10.92M. BIOL beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 46.34% of the time in the same period. current.com checksbetting odds for president 2024 IRVINE, Calif., June 8, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has entered into a securities purchase agreement with ... ge pension plan BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release second quarter 2023 financial and operating results on Thursday, August 10, 2023, after the ...Biolase price target lowered to $3.00 from $5.00 at Maxim November 15, 2023TipRanks. Positive Clinical Trial Results and Successful Cost Optimization Initiatives Bolster Buy Rating for Biolase ...